Compare · BZUN vs YI

BZUN vs YI

Side-by-side comparison of Baozun Inc. (BZUN) and 111 Inc. (YI): market cap, price performance, sector, and recent activity on the wire.

Summary

  • BZUN operates in Consumer Discretionary, while YI operates in Consumer Staples - the two are in different parts of the market.
  • BZUN is the larger of the two at $209.8M, about 8.1x YI ($25.8M).
  • BZUN has been more active in the news (5 items in the past 4 weeks vs 2 for YI).
  • BZUN has more recent analyst coverage (15 ratings vs 0 for YI).
MetricBZUNYI
Company
Baozun Inc.
111 Inc.
Price
-
-
Market cap
$209.8M
$25.8M
1M return
+4.02%
-
1Y return
+16.40%
-
Industry
Catalog/Specialty Distribution
Retail-Drug Stores and Proprietary Stores
Exchange
NASDAQ
NASDAQ
IPO
2015
2018
News (4w)
5
2
Recent ratings
15
0
BZUN

Baozun Inc.

Baozun Inc. provides e-commerce solutions to brand partners in the People's Republic of China. The company's integrated end-to-end brand e-commerce capabilities encompass various aspects of the e-commerce value chain, including IT solutions, online store operations, digital marketing, customer services, warehousing, and fulfillment. It serves brand partners in various categories, including apparel and accessories; appliances; electronics; home and furnishings; food and health products; beauty and cosmetics; fast moving consumer goods, and mother and baby products; and insurance and automobiles. The company was formerly known as Baozun Cayman Inc. and changed its name to Baozun Inc. in March 2015. Baozun Inc. was founded in 2007 and is headquartered in Shanghai, the People's Republic of China.

YI

111 Inc.

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.